DK3251678T3 - Benzoxaborolderivater til behandling af bakterieinfektioner - Google Patents

Benzoxaborolderivater til behandling af bakterieinfektioner Download PDF

Info

Publication number: DK3251678T3
Authority: DK; Denmark
Prior art keywords: benzoxaborol; derivatives; treatment; bacteria infections; infections
Prior art date: 2010-09-07

Application number

DK17176654.6T

Other languages

English (en)

Inventor

Vincent S Hernandez

Charles Ding

Jacob J Plattner

Michael Richard Kevin Alley

Fernando Rock

Eric Easom

Xianfeng Li

Ding Zhou

Suoming Zhang

Original Assignee

Anacor Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-09-07

Filing date

2011-09-07

Publication date

2021-11-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44653589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3251678(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-09-07 Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc

2021-11-22 Application granted granted Critical

2021-11-22 Publication of DK3251678T3 publication Critical patent/DK3251678T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK17176654.6T 2010-09-07 2011-09-07 Benzoxaborolderivater til behandling af bakterieinfektioner DK3251678T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US38059610P	2010-09-07	2010-09-07
EP11758050.6A EP2613788B1 (en)	2010-09-07	2011-09-07	Benzoxaborole derivatives for treating bacterial infections

Publications (1)

Publication Number	Publication Date
DK3251678T3 true DK3251678T3 (da)	2021-11-22

Family

ID=44653589

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK11758050.6T DK2613788T3 (da)	2010-09-07	2011-09-07	Benzoxaborolderivater til behandling af bakterieinfektioner
DK17176654.6T DK3251678T3 (da)	2010-09-07	2011-09-07	Benzoxaborolderivater til behandling af bakterieinfektioner

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK11758050.6T DK2613788T3 (da)	2010-09-07	2011-09-07	Benzoxaborolderivater til behandling af bakterieinfektioner

Country Status (25)

Country	Link
US (4)	US8703742B2 (da)
EP (2)	EP3251678B1 (da)
JP (4)	JP5952280B2 (da)
KR (2)	KR101949423B1 (da)
CN (2)	CN103140228A (da)
AU (1)	AU2011299243C1 (da)
BR (1)	BR112013005426B1 (da)
CA (1)	CA2810021C (da)
CY (1)	CY1124728T1 (da)
DK (2)	DK2613788T3 (da)
EA (2)	EA028743B1 (da)
ES (2)	ES2635333T3 (da)
HR (1)	HRP20211762T1 (da)
HU (1)	HUE059033T2 (da)
IL (2)	IL225000A (da)
LT (1)	LT3251678T (da)
MX (1)	MX338209B (da)
PL (1)	PL3251678T3 (da)
PT (1)	PT3251678T (da)
RS (1)	RS62548B1 (da)
SG (2)	SG10201507032YA (da)
SI (1)	SI3251678T1 (da)
SM (1)	SMT202100643T1 (da)
WO (1)	WO2012033858A2 (da)
ZA (1)	ZA201301598B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2635680A1 (en)	2005-12-30	2007-07-12	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
AP4039A (en)	2009-08-14	2017-02-28	Daitao Chen	Boron-containing small molecules as antiprotozoal agents
US8716478B2 (en)	2010-01-27	2014-05-06	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
PL3251678T3 (pl) *	2010-09-07	2022-01-10	Anacor Pharmaceuticals, Inc.	Pochodne benzoksaborolu do leczenia zakażeń bakteryjnych
WO2013093615A1 (en)	2011-12-22	2013-06-27	Micurx Pharmaceuticals, Inc.	Tricyclic boron compounds for antimicrobial therapy
US11039617B2 (en)	2013-01-30	2021-06-22	Agrofresh Inc.	Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
KR101666331B1 (ko)	2013-01-30	2016-10-13	다우 아그로사이언시즈 엘엘씨	육류, 식물, 또는 식물 부분에 대한 휘발성 항미생물제로서의 벤족사보롤의 용도
US8669207B1 (en)	2013-01-30	2014-03-11	Dow Agrosciences, Llc.	Compounds and compositions
US9585396B2 (en)	2013-01-30	2017-03-07	Agrofresh Inc.	Volatile applications against pathogens
US10070649B2 (en)	2013-01-30	2018-09-11	Agrofresh Inc.	Volatile applications against pathogens
WO2014121124A1 (en)	2013-02-01	2014-08-07	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as antiprotozoal agents
KR101636431B1 (ko)	2013-07-30	2016-07-05	동아에스티 주식회사	트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
SI3030519T1 (sl) *	2013-08-09	2022-04-29	Glaxosmithkline Intellectual Property (No.2) Limited	Triciklične benzoksaborolne spojine in njihove uporabe
EA038093B1 (ru) *	2013-12-20	2021-07-05	Глаксосмитклайн Интеллекчуал Проперти (№2) Лимитед	Способ лечения заболевания, вызванного инфекцией комплекса mycobacterium tuberculosis, с использованием (s)-(3-хлор-7,8-дигидро-2h-1,6,9-триокса-9a-борабензо[cd]азулен-2-ил)метанамина или его фармацевтически приемлемой соли
TW201625649A (zh)	2014-07-01	2016-07-16	第一三共股份有限公司	作爲抗菌劑的三環化合物
MA41494B1 (fr) *	2015-02-12	2020-10-28	Glaxosmithkline Ip No 2 Ltd	Composés benzoxaborole substitués en position 4 et utilisations associées
WO2017155879A1 (en)	2016-03-07	2017-09-14	Agrofresh Inc.	Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
EP3609504A4 (en)	2017-03-01	2021-03-03	Anacor Pharmaceuticals, Inc.	NEW OXABOROLE ANALOGUES AND USES OF THE LATEST
US11834466B2 (en)	2017-11-30	2023-12-05	5Metis, Inc.	Benzoxaborole compounds and formulations thereof
CN108727176B (zh) *	2018-07-26	2021-05-18	荆楚理工学院	一种制备5-卤-2,3-二羟基苯甲醛的方法
JP2021534247A (ja)	2018-08-18	2021-12-09	ボラゲン，インコーポレーテッド	置換ベンゾキサボロールの固体形態およびその組成物
US20220275007A1 (en) *	2019-07-30	2022-09-01	Boragen, Inc.	Flow reaction process for manufacture of boron-containing agrochemicals
CN110664756B (zh) *	2019-10-09	2020-11-17	吉林大学	一种小儿外伤喷雾剂及其制备方法
US20230340530A1 (en)	2020-08-31	2023-10-26	Pfizer Inc.	Methods of Protecting RNA
WO2023246841A1 (en) *	2022-06-23	2023-12-28	Shanghai Micurx Pharmaceutical Co., Ltd.	Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same
CN119233977A (zh) *	2022-06-23	2024-12-31	上海盟科药业股份有限公司	硼化合物的前药及其在治疗细菌感染中的用途
CN115572218B (zh) *	2022-08-29	2024-04-16	江阴勒森生物科技有限公司	一种2-溴-3-羟基苯甲醛及其相关化学发光底物中间体的制备方法

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2260336A (en)	1939-10-16	1941-10-28	Dow Chemical Co	Method of preparation of organic borates
US3686398A (en)	1970-07-20	1972-08-22	Chevron Res	10,9-boroxarophenanthrene as fungicides
GB1396904A (en)	1972-08-11	1975-06-11	Ici Ltd	Method for the control of micro-organisms
US4602011A (en)	1975-10-24	1986-07-22	Chapman Chemical Company	Antimicrobial compositions and methods of using same
US4766113A (en)	1975-10-24	1988-08-23	Chapman Chemical Company	Antimicrobial compositions and methods of using same
US4716035A (en)	1985-05-24	1987-12-29	The Procter & Gamble Company	Oral compositions and methods for treating gingivitis
US5962498A (en)	1986-06-11	1999-10-05	Procyon Pharmaceuticals, Inc.	Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity
US4894220A (en)	1987-01-30	1990-01-16	Colgate-Palmolive Company	Antibacterial antiplaque oral composition
US4919934A (en)	1989-03-02	1990-04-24	Richardson-Vicks Inc.	Cosmetic sticks
US5274792A (en)	1989-08-19	1993-12-28	Fujitsu Limited	Information processing apparatus with parallel instruction decoding
SG47101A1 (en)	1992-07-31	1998-03-20	Us Bioscience	Crystalline amifostine compositions and methods for the preparation and use of same
US5348947A (en)	1993-05-07	1994-09-20	American Cyanamid Company	Diarylboron ester and thioester fungicidal agents
US5348948A (en)	1993-05-07	1994-09-20	American Cyanamid Company	2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal
US5594151A (en)	1994-01-28	1997-01-14	Prolinx, Inc.	Phenylboronic acid complexing reagents derived from aminosalicylic acid
GB9411587D0 (en)	1994-06-09	1994-08-03	Zeneca Ltd	Compound, composition and use
US6083903A (en)	1994-10-28	2000-07-04	Leukosite, Inc.	Boronic ester and acid compounds, synthesis and uses
GB9500856D0 (en)	1995-01-17	1995-03-08	Zeneca Ltd	Composition and use
US6632955B1 (en)	1996-12-02	2003-10-14	Chisso Corporation	Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for preparing the same
GB9604926D0 (en)	1996-03-08	1996-05-08	Sandoz Ltd	Organic compounds
EP2223920A3 (en)	1996-06-19	2011-09-28	Aventis Pharma Limited	Substituted azabicyclic compounds
US5831046A (en)	1996-08-05	1998-11-03	Prolinx, Incorporated	Boronic acid-contaning nucleic acid monomers
AU4486097A (en)	1996-09-19	1998-04-14	Board Of Trustees Of The Leland Stanford Junior University	Dna adenine methyltransferases and uses thereof
US6221640B1 (en)	1997-05-14	2001-04-24	Cubist Pharmaceuticals, Inc.	Enterococcal aminoacyl-trna synthetase proteins, nucleic acids and strains comprising same
DE19829947A1 (de)	1998-07-04	2000-01-05	Bayer Ag	Elektrolumineszierende Anordnungen mit Bor-Chelaten
IL142584A0 (en)	1998-11-06	2002-03-10	Basf Ag	Tricyclic pyrazole derivatives
US6462036B1 (en)	1998-11-06	2002-10-08	Basf Aktiengesellschaft	Tricyclic pyrazole derivatives
WO2000044387A1 (fr)	1999-01-29	2000-08-03	Nitto Kasei Co., Ltd.	Composes organobores presentant une activite de coccidiostats
EP1181291A2 (en)	1999-05-25	2002-02-27	The Penn State Research Foundation	Dna methyltransferase inhibitors
AU775940B2 (en)	1999-08-25	2004-08-19	Ambergen, Inc.	Methods for the detection, analysis and isolation of nascent proteins
US6306628B1 (en)	1999-08-25	2001-10-23	Ambergen, Incorporated	Methods for the detection, analysis and isolation of Nascent proteins
WO2001025226A1 (en)	1999-10-05	2001-04-12	Bethesda Pharmaceuticals, Inc.	Dithiolane derivatives
WO2001049303A1 (en)	2000-01-06	2001-07-12	Marantech Holding, Llc	Multivalent electron active compositions and methods of making and using same
US6521619B2 (en)	2000-06-29	2003-02-18	Icos Corporation	Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
WO2002006316A2 (en)	2000-07-14	2002-01-24	Zycos, Inc.	Alpha-msh related compounds and methods of use
JP2004524281A (ja)	2000-11-30	2004-08-12	ザペンステートリサーチファウンデイション	Ｄｎａメチルトランスフェラーゼ阻害剤
DE10110051C2 (de)	2001-03-02	2003-07-03	Clariant Gmbh	Verfahren zur Herstellung von Boron- und Borinsäuren
US7766013B2 (en)	2001-06-05	2010-08-03	Alexza Pharmaceuticals, Inc.	Aerosol generating method and device
CA2446904A1 (en)	2001-05-24	2003-04-03	Alexza Molecular Delivery Corporation	Delivery of drug esters through an inhalation route
GB0117645D0 (en)	2001-07-19	2001-09-12	Isis Innovation	Therapeutic stratergies for prevention and treatment of alzheimers disease
DE10143979A1 (de)	2001-09-07	2003-03-27	Clariant Gmbh	Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren
JPWO2003033002A1 (ja)	2001-10-11	2005-02-03	御子柴　克彦	細胞内カルシウム濃度上昇抑制剤
EP1463739A2 (en)	2002-01-10	2004-10-06	The Pennsylvania State Research Foundation	Methods for the preparation of alkyl diaryl borinates and complexed diarylborinic acids
US20040077601A1 (en)	2002-07-09	2004-04-22	Point Therapeutics, Inc.	Methods and compositions relating to isoleucine boroproline compounds
DE60313357T2 (de)	2002-12-02	2008-01-03	Solvias Ag	Verfahren zur katalytischen hydrierung von kohlenstoff-heteroatom-doppelbindungen
US7390806B2 (en)	2002-12-18	2008-06-24	Anacor Pharmaceuticals, Inc.	Antibiotics containing borinic acid complexes and methods of use
BR0317564A (pt)	2002-12-18	2005-11-22	Anacor Pharmaceuticals Inc	Compostos, composições e métodos para tratar doenças causadas por bactérias ou fungos
WO2005000200A2 (en)	2003-05-09	2005-01-06	Sugen, Inc.	Novel kinases
CA2529792A1 (en)	2003-06-16	2005-02-17	Anacor Pharmaceuticals, Inc.	Hydrolytically-resistant boron-containing therapeutics and methods of use
PT1755661E (pt)	2004-05-12	2014-06-03	Brigham & Womens Hospital	A utilização de gelsolina para o tratamento de infeções
AR049915A1 (es)	2004-06-14	2006-09-13	Anacor Pharmaceuticals Inc	Compuestos con contenido de boro y metodos de uso de los mismos
WO2006062731A1 (en)	2004-11-19	2006-06-15	University Of North Texas Health Science Center At Fort Worth	Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye
GB0501944D0 (en)	2005-01-31	2005-03-09	Univ Cambridge Tech	Compounds for use in chemical detection and/or quantitation
SI3424932T1 (sl)	2005-02-16	2021-08-31	Anacor Pharmaceuticals, Inc.	Boronoftalidi za terapevtsko uporabo
US7919422B2 (en)	2005-03-08	2011-04-05	Agency For Science, Technology And Research	Chiral bisoxazoline catalysts
US20060251689A1 (en)	2005-03-30	2006-11-09	Astion Development A/S	Treatment or prevention of pruritus
US20080234229A1 (en)	2005-08-18	2008-09-25	Auspex Pharmaceuticals, Inc.	Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders
CA2635680A1 (en)	2005-12-30	2007-07-12	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
EP1988779B1 (en)	2006-02-16	2015-06-24	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as anti-inflammatory agents
CA2651212A1 (en) *	2006-05-02	2007-11-15	Anacor Pharmaceuticals, Inc.	Hydrolytically-resistant boron-containing therapeutics and methods of use
US20070286822A1 (en)	2006-06-12	2007-12-13	Anacor Pharmaceuticals Inc.	Compounds for the Treatment of Periodontal Disease
RU2008152367A (ru)	2006-06-12	2010-07-20	Анакор Фармасьютикалз, Инк. (Us)	Соединения для лечения периодонтального заболевания
KR100848491B1 (ko)	2007-01-16	2008-07-28	영진약품공업주식회사	베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
JO3396B1 (ar)	2007-06-20	2019-10-20	Anacor Pharmaceuticals Inc	جزيئات صغيرة تحتوي على البورون
EP2187893A4 (en)	2008-03-06	2012-02-22	Anacor Pharmaceuticals Inc	SMALL BORON-CONTAINING MOLECULES AS ANTI-INFLAMMATORY AGENTS
RU2547441C2 (ru)	2008-03-06	2015-04-10	Анакор Фармасьютикалз, Инк.	Борсодержащие малые молекулы в качестве противовоспалительных агентов
WO2009140309A2 (en)	2008-05-12	2009-11-19	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
WO2010028005A1 (en)	2008-09-04	2010-03-11	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
WO2010045505A1 (en)	2008-10-15	2010-04-22	Anacor Pharmaceuticals, Inc	Boron-containing small molecules as anti-protozoal agents
WO2010045503A1 (en)	2008-10-15	2010-04-22	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as anti-protozoal agents
CA2744231A1 (en)	2008-12-17	2010-07-15	Anacor Pharmaceuticals, Inc.	Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol
MX2012001156A (es)	2009-07-28	2012-05-08	Anacor Pharmaceuticals Inc	Moleculas que contienen boro trisustituidas.
PL3251678T3 (pl) *	2010-09-07	2022-01-10	Anacor Pharmaceuticals, Inc.	Pochodne benzoksaborolu do leczenia zakażeń bakteryjnych

2011
- 2011-09-07 PL PL17176654T patent/PL3251678T3/pl unknown
- 2011-09-07 MX MX2013002651A patent/MX338209B/es active IP Right Grant
- 2011-09-07 SG SG10201507032YA patent/SG10201507032YA/en unknown
- 2011-09-07 KR KR1020137005717A patent/KR101949423B1/ko active Active
- 2011-09-07 CN CN2011800427618A patent/CN103140228A/zh active Pending
- 2011-09-07 LT LTEP17176654.6T patent/LT3251678T/lt unknown
- 2011-09-07 KR KR1020197003860A patent/KR102152901B1/ko active Active
- 2011-09-07 US US13/227,444 patent/US8703742B2/en active Active
- 2011-09-07 PT PT171766546T patent/PT3251678T/pt unknown
- 2011-09-07 WO PCT/US2011/050728 patent/WO2012033858A2/en not_active Ceased
- 2011-09-07 EP EP17176654.6A patent/EP3251678B1/en active Active
- 2011-09-07 JP JP2013527375A patent/JP5952280B2/ja active Active
- 2011-09-07 SM SM20210643T patent/SMT202100643T1/it unknown
- 2011-09-07 EA EA201390274A patent/EA028743B1/ru not_active IP Right Cessation
- 2011-09-07 CN CN201810051113.2A patent/CN108610356B/zh active Active
- 2011-09-07 HU HUE17176654A patent/HUE059033T2/hu unknown
- 2011-09-07 DK DK11758050.6T patent/DK2613788T3/da active
- 2011-09-07 ES ES11758050.6T patent/ES2635333T3/es active Active
- 2011-09-07 EA EA201791850A patent/EA033311B1/ru unknown
- 2011-09-07 BR BR112013005426-3A patent/BR112013005426B1/pt active IP Right Grant
- 2011-09-07 HR HRP20211762TT patent/HRP20211762T1/hr unknown
- 2011-09-07 SG SG2013014493A patent/SG187969A1/en unknown
- 2011-09-07 SI SI201132017T patent/SI3251678T1/sl unknown
- 2011-09-07 AU AU2011299243A patent/AU2011299243C1/en active Active
- 2011-09-07 CA CA2810021A patent/CA2810021C/en active Active
- 2011-09-07 EP EP11758050.6A patent/EP2613788B1/en active Active
- 2011-09-07 DK DK17176654.6T patent/DK3251678T3/da active
- 2011-09-07 RS RS20211391A patent/RS62548B1/sr unknown
- 2011-09-07 ES ES17176654T patent/ES2898695T3/es active Active
2013
- 2013-02-28 IL IL225000A patent/IL225000A/en active IP Right Grant
- 2013-03-01 ZA ZA2013/01598A patent/ZA201301598B/en unknown
2014
- 2014-03-21 US US14/221,637 patent/US9751898B2/en active Active
2016
- 2016-03-13 IL IL244556A patent/IL244556B/en active IP Right Grant
- 2016-06-09 JP JP2016114971A patent/JP2016199558A/ja not_active Withdrawn
2017
- 2017-08-24 US US15/685,846 patent/US20170355719A1/en not_active Abandoned
- 2017-10-06 JP JP2017195759A patent/JP6491294B2/ja active Active
2019
- 2019-02-28 JP JP2019035145A patent/JP2019112431A/ja active Pending
- 2019-07-30 US US16/526,248 patent/US11008345B2/en active Active
2021
- 2021-11-16 CY CY20211100990T patent/CY1124728T1/el unknown

Also Published As

Publication number	Publication date
ES2635333T3 (es)	2017-10-03
EA033311B1 (ru)	2019-09-30
BR112013005426A2 (pt)	2016-06-07
CA2810021C (en)	2018-05-29
IL244556A0 (en)	2016-04-21
CY1124728T1 (el)	2022-07-22
IL244556B (en)	2020-07-30
AU2011299243C1 (en)	2016-06-02
EP3251678B1 (en)	2021-10-20
ZA201301598B (en)	2021-08-25
IL225000A (en)	2016-03-31
EA201390274A1 (ru)	2013-08-30
SI3251678T1 (sl)	2022-01-31
WO2012033858A3 (en)	2012-05-10
JP2018058836A (ja)	2018-04-12
AU2011299243B2 (en)	2015-09-17
RS62548B1 (sr)	2021-12-31
EP3251678A1 (en)	2017-12-06
JP5952280B2 (ja)	2016-07-13
US20120115813A1 (en)	2012-05-10
AU2011299243A1 (en)	2013-03-28
CN108610356A (zh)	2018-10-02
PT3251678T (pt)	2021-11-22
US9751898B2 (en)	2017-09-05
LT3251678T (lt)	2021-12-10
SG10201507032YA (en)	2015-10-29
CN103140228A (zh)	2013-06-05
US20170355719A1 (en)	2017-12-14
DK2613788T3 (da)	2017-08-07
JP6491294B2 (ja)	2019-03-27
HK1247841A1 (en)	2018-10-05
EA201791850A1 (ru)	2018-01-31
EP2613788B1 (en)	2017-06-21
WO2012033858A2 (en)	2012-03-15
JP2016199558A (ja)	2016-12-01
BR112013005426B1 (pt)	2021-08-24
US8703742B2 (en)	2014-04-22
ES2898695T3 (es)	2022-03-08
JP2019112431A (ja)	2019-07-11
EP2613788A2 (en)	2013-07-17
HRP20211762T1 (hr)	2022-02-18
KR101949423B1 (ko)	2019-02-18
US20190345173A1 (en)	2019-11-14
MX338209B (es)	2016-04-07
US20140315860A1 (en)	2014-10-23
CA2810021A1 (en)	2012-03-15
PL3251678T3 (pl)	2022-01-10
MX2013002651A (es)	2013-04-19
CN108610356B (zh)	2021-02-26
JP2013541514A (ja)	2013-11-14
KR102152901B1 (ko)	2020-09-07
KR20140093598A (ko)	2014-07-28
KR20190018549A (ko)	2019-02-22
HUE059033T2 (hu)	2022-10-28
SMT202100643T1 (it)	2022-01-10
US11008345B2 (en)	2021-05-18
EA028743B1 (ru)	2017-12-29
ES2898695T8 (es)	2022-03-16
SG187969A1 (en)	2013-04-30

Publication	Publication Date	Title
DK3251678T3 (da)	2021-11-22	Benzoxaborolderivater til behandling af bakterieinfektioner
LTC2785706I2 (lt)	2023-07-10	Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
DK3590928T3 (da)	2021-08-30	Pyrimidinderivater til behandling af virusinfektioner
DK3520805T3 (da)	2021-04-19	Sammensætninger til behandling af myelofibrose
DK2498771T3 (da)	2014-01-27	Anvendelse af bethanechol til behandling af xerostomi
DK2852391T3 (da)	2022-02-21	Systemer til behandling af lungeinfektioner
HRP20180972T1 (hr)	2018-10-05	Kombinacija fenoksibenzamina i polimiksina e za liječenje mikrobnih infekcija
LT2558105T (lt)	2020-02-10	Bardoksolono metilas, skirtas nutukimo gydymui
BR112013014943A2 (pt)	2016-09-13	compostos úteis para o tratamento de aids
HRP20180237T1 (hr)	2018-03-09	Metode za liječenje hcv-a
ZA201405820B (en)	2016-05-25	Piperidino-pyrimidine derivatives for the treatment of viral infections
PL2523661T3 (pl)	2017-09-29	Inhibitory NKCC do leczenia autyzmu
PL2925729T3 (pl)	2018-04-30	Heterocykliczne podstawione pochodne 2-amino-chinazoliny do leczenia infekcji wirusowych
DK3403669T3 (da)	2020-08-24	Fremgangsmåder til behandling og forebyggelse af staphylococcus aureus-infektioner og forbundne tilstande
DK2861214T3 (da)	2020-10-12	Tilpassede liposomer til behandling af bakterieinfektioner
PL2696890T3 (pl)	2021-12-27	Leczenie infekcji drobnoustrojowych
DK2773648T3 (da)	2019-05-20	Farmaceutiske forbindelser til anvendelse i behandlingen af clostridium difficile-infektion
PL2658851T3 (pl)	2015-08-31	Związki heterocykliczne odpowiednie do leczenia dyslipidemii
SMT201600059B (it)	2016-04-29	Trattamento di infezioni da streptococco
DK2501381T3 (da)	2017-11-06	Behandling af atrieflimmer
IL227747A0 (en)	2013-09-30	Combinations comprising macitentan for the treatment of glioblastoma multiforme
DK2701707T3 (da)	2020-11-02	Fremgangsmåde til behandling af dyskinesi
ITRM20120473A1 (it)	2014-04-05	Use of glycerophosphoinositols for the treatment of septic shock
DK2455064T3 (da)	2021-02-22	Indretning til behandling af periodontal sygdom
FR2994506B1 (fr)	2015-11-27	Adaptation de transistors